M12 co-led a $22m series A round for the drug discovery technology developer with Playground Global, and both investors have taken board seats.

US-based drug development technology developer 1910 Genetics emerged from stealth yesterday having completed a $22m series A round featuring software producer Microsoft’s corporate venturing unit, M12. Venture capital firm Playground Global co-led the round, which followed a $4.1m seed round led by Sam Altman and backed by fellow angel investors including Tuck Lye Koh as…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.